The currently reported anti-obesity mechanisms of COS mainly include inhibition of apolipoprotein B (ApoB) levels, PPAR-γ, bile acid secretion, pancreatic lipase production and reduction of serum ghrelin concomitant with increasing leptin (8). The gene discussed is APOB; the disease is obesity due to melanocortin 4 receptor deficiency.